Cargando…
Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target
Interleukin (IL)-34 is a cytokine discovered a few years ago and identified as the second colony-stimulating factor (CSF)-1 receptor (CSF-1R) ligand. Although CSF-1 and IL-34 share the same receptor through which they trigger similar effects, IL-34 also binds to receptors protein-tyrosine phosphatas...
Autores principales: | Ge, Yun, Huang, Man, Yao, Yong-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743287/ https://www.ncbi.nlm.nih.gov/pubmed/31523186 http://dx.doi.org/10.7150/ijbs.35070 |
Ejemplares similares
-
Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis
por: Ge, Yun, et al.
Publicado: (2020) -
Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles
por: Pandey, Ashutosh, et al.
Publicado: (2022) -
Immunomodulators: interleukins, interferons, and IV immunoglobulin
por: Roelofs, Joris J., et al.
Publicado: (2008) -
Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy
por: Petrof, Basil J., et al.
Publicado: (2023) -
Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis
por: Liu, Qinghua, et al.
Publicado: (2020)